BioXcel Therapeutics Inc
NASDAQ:BTAI 4:00:00 PM EDT
| Market Cap (Intraday) | 43.81M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $3.32 |
| 50-Day MA | $3.37 |
| 200-Day MA | $3.22 |
BioXcel Therapeutics Inc Stock, NASDAQ:BTAI
555 Long Wharf Drive, 12th floor, New Haven, Connecticut 06511
United States of America
Phone: +1.475.238.6837
Number of Employees: 74
Description
BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.